β-Amyloid regulates gene expression of glial trophic substance S100β in C6 glioma and primary astrocyte cultures

[1]  R. Rydel,et al.  Amyloid beta peptide potentiates cytokine secretion by interleukin-1 beta-activated human astrocytoma cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[2]  W. Griffin,et al.  S100β protein expression in Alzheimer disease: Potential role in the pathogenesis of neuritic plaques , 1994 .

[3]  M. Nedergaard,et al.  Direct signaling from astrocytes to neurons in cultures of mammalian brain cells. , 1994, Science.

[4]  J. Silver,et al.  β-Amyloid of Alzheimer's Disease Induces Reactive Gliosis That Inhibits Axonal Outgrowth , 1993, Experimental Neurology.

[5]  Mark P. Mattson,et al.  β-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease , 1993, Trends in Neurosciences.

[6]  D. Selkoe.  Physiological production of the β-amyloid protein and the mechanism of Alzheimer's disease , 1993, Trends in Neurosciences.

[7]  E. Burcher,et al.  Tachykinin Receptors: A Radioligand Binding Perspective , 1993, Journal of neurochemistry.

[8]  D. Lahiri.  The stability of β-amyloid precursor protein in nine different cell types , 1993 .

[9]  S. Fulle,et al.  The S-100 protein causes an increase of intracellular calcium and death of PC12 cells , 1993, Neuroscience.

[10]  P. Matsudaira,et al.  Generation of beta-amyloid in the secretory pathway in neuronal and nonneuronal cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[11]  E. Rojas,et al.  Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[12]  S. Barger,et al.  Disulfide-linked S100β dimers and signal transduction , 1992 .

[13]  P. Lantos,et al.  Astrocytosis, βA4-protein deposition and paired helical filament formation in Alzheimer's disease , 1992, Journal of the Neurological Sciences.

[14]  J. Lauder,et al.  S‐100β and insulin‐like growth factor‐II differentially regulate growth of developing serotonin and dopamine neurons in vitro , 1992, Journal of neuroscience research.

[15]  D. K. Rush,et al.  Intracerebral /sB-amyloid(25–35) produces tissue damage: Is it neurotoxic? , 1992, Neurobiology of Aging.

[16]  C. Cotman,et al.  β-Amyloid neurotoxicity: A discussion of in vitro findings , 1992, Neurobiology of Aging.

[17]  A. Scheibel,et al.  Immunohistochemical analysis of the basal forebrain in Alzheimer's disease. , 1992, Molecular and chemical neuropathology.

[18]  J. Shioi,et al.  Chondroitin sulfate proteoglycan form of the Alzheimer's beta-amyloid precursor. , 1992, The Journal of biological chemistry.

[19]  R. Oppenheim,et al.  S100 is present in developing chicken neurons and Schwann cells and promotes motor neuron survival in vivo. , 1992, Journal of neurobiology.

[20]  S. Barger,et al.  S100 beta stimulates calcium fluxes in glial and neuronal cells. , 1992, The Journal of biological chemistry.

[21]  K S Kosik,et al.  Alzheimer's disease: a cell biological perspective. , 1992, Science.

[22]  R. Frederickson.  Astroglia in Alzheimer's disease , 1992, Neurobiology of Aging.

[23]  D. Marshak,et al.  Increased S100β neurotrophic activity in Alzheimer's disease temporal lobe , 1992, Neurobiology of Aging.

[24]  C. L. Johnson,et al.  Characterization of Receptors for Substance P in Human Astrocytoma Cells: Radioligand Binding and Inositol Phosphate Formation , 1992, Journal of neurochemistry.

[25]  M. Mattson,et al.  beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[26]  C. Cotman,et al.  β-Amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer's disease , 1992, Brain Research.

[27]  E. Azmitia,et al.  S100 beta and serotonin: a possible astrocytic-neuronal link to neuropathology of Alzheimer's disease. , 1992 .

[28]  D. Marshak,et al.  Potential role of S100 beta in Alzheimer's disease: an hypothesis involving mitotic protein kinases. , 1992, Progress in clinical and biological research.

[29]  R. Donato.  Perspectives in S-100 protein biology. Review article. , 1991, Cell calcium.

[30]  S. Hirai,et al.  Expression of APP in the early stage of brain damage , 1991, Brain Research.

[31]  K. Haglid,et al.  Determination of S‐100 and Glial Fibrillary Acidic Protein Concentrations in Cerebrospinal Fluid After Brain Infarction , 1991, Stroke.

[32]  M. Mitsuhashi,et al.  Amyloid beta protein substituent peptides do not interact with the substance P receptor expressed in cultured cells. , 1991, Brain research. Molecular brain research.

[33]  M. Beal,et al.  An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance P. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[34]  S. Barger,et al.  Neurotrophic protein S100 beta stimulates glial cell proliferation. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[35]  E. Shooter,et al.  Neurotrophic activity of S-100β in cultures of dorsal root ganglia from embryonic chick and fetal rat , 1991, Brain Research.

[36]  C. Cotman,et al.  β-Amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage , 1990, Brain Research.

[37]  D. Kirschner,et al.  Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. , 1990, Science.

[38]  R. Balázs,et al.  Neuronal plasticity and astrocytic reaction in Down syndrome and Alzheimer disease , 1990, Journal of the Neurological Sciences.

[39]  E. Azmitia,et al.  S-100B but not NGF, EGF, insulin or calmodulin is a CNS serotonergic growth factor , 1990, Brain Research.

[40]  T. Mandybur,et al.  Astrocytes and the plaques of Alzheimer's disease , 1990, Neurology.

[41]  A. D. Hershey,et al.  Molecular Biological Studies on the Diversity of Chemical Signalling in Tachykinin Peptidergic Neurons a , 1990, Annals of the New York Academy of Sciences.

[42]  J. Glowinski,et al.  Marked Regional Heterogeniety of 125I‐Bolton Hunter Substance P Binding and Substance P‐Induced Activation of Phospholipase C in Astrocyte Cultures from the Embryonic or Newborn Rat , 1990, Journal of neurochemistry.

[43]  A. Delacourte.  General and dramatic glial reaction in Alzheimer brains , 1990, Neurology.

[44]  J. de Vellis,et al.  Transcriptional regulation studies of myelin-associated genes in myelin-deficient mutant rats. , 1990, Developmental neuroscience.

[45]  D. Marshak.  S100 beta as a neurotrophic factor. , 1990, Progress in brain research.

[46]  T. Shnitka,et al.  Reactive astrocytes--a review. , 1990, Cytobios.

[47]  W. Griffin,et al.  Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[48]  W. Tourtellotte,et al.  Changes in brain gene expression shared by scrapie and Alzheimer disease. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[49]  Robert B. Nelson,et al.  Expression of β-amyloid precursor protein in reactive astrocytes following neuronal damage , 1989, Neuron.

[50]  G. Cole,et al.  Amyloid beta protein precursor is a mitogen. , 1989, Biochemical and biophysical research communications.

[51]  J. de Vellis,et al.  Tis gene expression in cultured rat astrocytes: Multiple pathways of induction by mitogens , 1989, Journal of neuroscience research.

[52]  R. Martins,et al.  Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. , 1989, The New England journal of medicine.

[53]  E. Schon,et al.  Widespread expression of amyloid beta-protein precursor gene in rat brain. , 1989, The American journal of pathology.

[54]  C. Cotman,et al.  Amyloid beta protein enhances the survival of hippocampal neurons in vitro. , 1989, Science.

[55]  C. Cotman,et al.  Calcium, membranes, aging, and Alzheimer's disease , 1989 .

[56]  A. Shahar.  A Dissection and tissue culture manual of the nervous system , 1989 .

[57]  Glenner Gg.  Amyloid beta protein and the basis for Alzheimer's disease. , 1989 .

[58]  G. Multhaup,et al.  Alzheimer's disease amyloidogenic glycoprotein: expression pattern in rat brain suggests a role in cell contact. , 1988, The EMBO journal.

[59]  F. Suzuki,et al.  S‐100 Protein in Clonal Astroglioma Cells Is Released by Adrenocorticotropic Hormone and Corticotropin‐Like Intermediate‐Lobe Peptide , 1987, Journal of neurochemistry.

[60]  H. Schägger,et al.  Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. , 1987, Analytical biochemistry.

[61]  M. Zupancic,et al.  The molecular pathogenesis of astrogliosis in scrapie and Alzheimer's disease. , 1987, Microbial pathogenesis.

[62]  M. Nieto‐Sampedro.  Astrocyte mitogenic activity in aged normal and Alzheimer's human brain , 1987, Neurobiology of Aging.

[63]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[64]  A. Hirano,et al.  Nucleus raphe dorsalis in Alzheimer's disease: Neurofibrillary tangles and loss of large neurons , 1985, Annals of neurology.

[65]  C. Dani,et al.  Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. , 1985, Nucleic acids research.

[66]  H. Wiśniewski,et al.  Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome , 1985, Annals of neurology.

[67]  B. Moore,et al.  Proteins of the Brain Extracellular Fluid: Evidence for Release of S‐100 Protein , 1984, Journal of neurochemistry.

[68]  G. Glenner,et al.  Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein , 1984 .

[69]  M. Shelanski,et al.  Sequence of a cDNA clone encoding mouse glial fibrillary acidic protein: structural conservation of intermediate filaments. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[70]  F. Suzuki,et al.  Regulation of Nervous System‐Specific S‐100 Protein and Enolase Levels in Adipose Tissue by Catecholamines , 1984, Journal of neurochemistry.

[71]  R. Terry,et al.  Fibrous Astrocytes in Senile Dementia of the Alzheimer Type , 1981, Journal of neuropathology and experimental neurology.

[72]  M. Rapport,et al.  Glial fibrillary acidic protein and Alzheimer‐type senile dementia , 1980, Neurology.

[73]  L. Levine,et al.  Differentiated Rat Glial Cell Strain in Tissue Culture , 1968, Science.